GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » Net Margin %

Big Pharma Split (TSX:PRM) Net Margin % : 85.73% (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Big Pharma Split's Net Income for the six months ended in Jun. 2024 was C$1.50 Mil. Big Pharma Split's Revenue for the six months ended in Jun. 2024 was C$1.75 Mil. Therefore, Big Pharma Split's net margin for the quarter that ended in Jun. 2024 was 85.73%.

The historical rank and industry rank for Big Pharma Split's Net Margin % or its related term are showing as below:

TSX:PRM' s Net Margin % Range Over the Past 10 Years
Min: -44.87   Med: 79.36   Max: 90.58
Current: 77.61


TSX:PRM's Net Margin % is ranked worse than
56.39% of 1644 companies
in the Asset Management industry
Industry Median: 87.78 vs TSX:PRM: 77.61

Big Pharma Split Net Margin % Historical Data

The historical data trend for Big Pharma Split's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Net Margin % Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial 88.79 44.99 90.58 84.77 -44.87

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.49 71.82 312.75 43.24 85.73

Competitive Comparison of Big Pharma Split's Net Margin %

For the Asset Management subindustry, Big Pharma Split's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Big Pharma Split's Net Margin % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's Net Margin % distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's Net Margin % falls into.



Big Pharma Split Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Big Pharma Split's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.14/0.312
=-44.87 %

Big Pharma Split's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=1.502/1.752
=85.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Big Pharma Split  (TSX:PRM) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Big Pharma Split Net Margin % Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Big Pharma Split Business Description

Traded in Other Exchanges
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Executives
Michael Kovacs Director, Senior Officer

Big Pharma Split Headlines

From GuruFocus

Top 5 2nd Quarter Trades of Stanley Capital Management, LLC

By GuruFocus Research GuruFocus Editor 08-16-2022

Perimeter Solutions SA (PRM) Stock Price Up 4.9% on Sep 24

By GuruFocus Research 09-24-2024

Q2 2022 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 02-11-2024

Q3 2021 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 02-11-2024

Q4 2021 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 02-11-2024

Q3 2023 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 02-11-2024

EQUITABLE TRUST CO Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-21-2023